BioLargo, Inc. BLGO
$0.09
$0.00-1.97%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -2.77M | -2.29M | -2.95M | -6.48M | -1.19M |
| Total Depreciation and Amortization | 113.00K | 111.00K | 137.00K | 103.00K | 81.00K |
| Total Amortization of Deferred Charges | 70.00K | 62.00K | 90.00K | 39.00K | 39.00K |
| Total Other Non-Cash Items | -297.00K | -445.00K | 48.00K | 3.91M | -16.00K |
| Change in Net Operating Assets | -175.00K | -359.00K | 1.09M | -333.00K | -1.03M |
| Cash from Operations | -3.06M | -2.92M | -1.59M | -2.76M | -2.12M |
| Capital Expenditure | -160.00K | -32.00K | -13.00K | -33.00K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 0.00 | 289.00K | 192.00K |
| Cash from Investing | -160.00K | -32.00K | -13.00K | 256.00K | 192.00K |
| Total Debt Issued | 1.00M | 2.40M | -26.00K | 0.00 | 721.00K |
| Total Debt Repaid | -142.00K | -8.00K | 18.00K | -9.00K | -5.00K |
| Issuance of Common Stock | 391.00K | 341.00K | 960.00K | 3.04M | 793.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | 0.00 | 2.15M | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 30.00K | 462.00K | -- | -1.60M | 1.32M |
| Cash from Financing | 1.28M | 3.19M | 952.00K | 3.57M | 2.83M |
| Foreign Exchange rate Adjustments | 3.00K | -2.00K | -12.00K | 8.00K | 0.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.93M | 239.00K | -663.00K | 1.08M | 907.00K |